Invited discussant

• Reference

• 1 Boissel J.P.. 1978; Prevention des accidents thrombo-emboliques systémiques chez les porteurs de prothèses valvulaires artificielles: essai coopératif contrôlé du dipyridamole, Coeur. 9: 915.
• 2 Canner P.L.. 1978; Monitoring clinical trial for evidence of adverse or beneficial treatment effects.. In Boissel J.P., Klimt C.R.. Multicenter Controlled Clinical Trials. Principles and problems, INSERM 76: 1979.
• 3 C.D.P. Research Group. 1975; Clofibrate and Niacin in Coronary Heart Disease.. Journal of American Medical Association 231: 360.
• 4 Meinert C.L.. 1978; Quality Assurance and Clinical Evaluation of Treatments. In Boissel J.P., Klimt C.R.. Multicenter Controlled Clinical Trials. Principles and problems, INSERM 76: 1979.
• 5 Oliver M.F.. 1971; Ischaemic heart disease: A secondary prevention trial using Clofibrate.. British Medical Journal 4: 775.